The COS is pleased to provide access to the presentations from the co-developed symposium Non-Infectious Uveitis: What’s Best For My Patient: Local or Systemic Treatment?, which took place at the 2018 COS Annual Meeting in Toronto, Ontario. Through these presentations, International and Canadian expert faculty lead a discussion around the various treatment strategies for uveitis, how to choose the most appropriate line of therapy for different uveitis presentations. A novel model of collaborative care between ophthalmology and rheumatology was also presented. Below, you will find a video of the presentation by each speaker.
Note on CPD credits: Scanning resources that are relevant to your professional practice by enhancing your awareness of new evidence, perspectives and findings can be claimed as Section 2: Self-Learning under Scanning in MAINPORT with the MOC Program of the Royal College of Physicians and Surgeons of Canada.
Presentation 1: Use of Anti-VEGFs in uveitis
Dr. Amin Kherani reviews the epidemiology and pathogenesis of VEGF, then explains the management of uveitis and the role of anti-VEGF therapy.
Presentation 2: Topical and injected corticosteroids: When are they appropriate? When are they not?
Dr. Chloe Gottlieb discusses the appropriate use of topical and periocular steroids for treating uveitis, the steroid-related complications that limit this use, and the benefit of additional therapies.
Presentation 3: Intraocular implants vs. immunosuppression
Dr. Marc de Smet covers conventional uveitis medications, and compares immunosuppressive treatment options.
Presentation 4: Immunosuppression for uveitis: What, when, how, and by whom?
Dr. Larissa Derzko-Dzulynsky expands on the area of immunosuppression for uveitis, highlighting first line and second line treatments, including biologics.
Presentation 5: Collaboration between ophthalmologists and rheumatologists for patients with uveitis
Dr. Olga Ziouzina presents a collaborative care model for uveitis treatment, drawing from her own experience at a combined multidisciplinary uveitis clinic in Calgary.
Panel discussion
At the end of the session, moderator and Chair, Dr. Eric Fortin leads the audience and faculty through a series of questions related to Non-Infectious Uveitis: What’s Best For My Patient: Local or Systemic Treatment?
In collaboration with the Canadian Ophthalmological Society, the Canadian Retina Society, and the Canadian Uveitis Society. This symposium was co-developed with AbbVie and was planned to achieve scientific integrity, objectivity and balance.